Explore Tumor Heterogeneity from Single Sample Using Multiomics

Harnessing the Power of Multiomics from a Single Sample to Explore Tumor Heterogeneity and Advance Immuno-Oncology Research

The omics era has greatly expanded the repertoire of approaches available for researchers and clinicians to unravel the complexity behind cancer onset in humans: Next Generation Sequencing (NGS) approaches can characterize genomes, epigenomes, transcriptomes, and proteomes of patient samples. In this poster, we present a workflow to rapidly produce a diverse set of multiomic results from a single blood draw.